Utility of CT radiomics for prediction of PD-L1 expression in advanced lung adenocarcinomas

被引:69
|
作者
Yoon, Jiyoung [1 ]
Suh, Young Joo [1 ]
Han, Kyunghwa [1 ]
Cho, Hyoun [1 ]
Lee, Hye-Jeong [1 ]
Hur, Jin [1 ]
Choi, Byoung Wook [1 ]
机构
[1] Yonsei Univ, Severance Hosp, Coll Med, Res Inst Radiol Sci,Dept Radiol, Seoul, South Korea
关键词
Computed tomography; immunotherapy; lung adenocarcinoma; programmed death ligand 1; radiomics; FACTOR RECEPTOR MUTATION; DEATH LIGAND 1; EGFR MUTATION; INTERNATIONAL ASSOCIATION; COMPUTED-TOMOGRAPHY; TEXTURE ANALYSIS; STAGE-I; CANCER; CLASSIFICATION; FEATURES;
D O I
10.1111/1759-7714.13352
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background We aimed to assess if quantitative radiomic features can predict programmed death ligand 1 (PD-L1) expression in advanced stage lung adenocarcinoma. Methods This retrospective study included 153 patients who had advanced stage (>IIIA by TNM classification) lung adenocarcinoma with pretreatment thin section computed tomography (CT) images and PD-L1 expression test results in their pathology reports. Clinicopathological data were collected from electronic medical records. Visual analysis and radiomic feature extraction of the tumor from pretreatment CT were performed. We constructed two models for multivariate logistic regression analysis (one based on clinical variables, and the other based on a combination of clinical variables and radiomic features), and compared c-statistics of the receiver operating characteristic curves of each model to identify the model with the higher predictability. Results Among 153 patients, 53 patients were classified as PD-L1 positive and 100 patients as PD-L1 negative. There was no significant difference in clinical characteristics or imaging findings on visual analysis between the two groups (P > 0.05 for all). Rad-score by radiomic analysis was higher in the PD-L1 positive group than in the PD-L1 negative group with a statistical significance (-0.378 +/- 1.537 vs. -1.171 +/- 0.822, P = 0.0008). A prediction model that uses clinical variables and CT radiomic features showed higher performance compared to a prediction model that uses clinical variables only (c-statistic = 0.646 vs. 0.550, P = 0.0299). Conclusions Quantitative CT radiomic features can predict PD-L1 expression in advanced stage lung adenocarcinoma. A prediction model composed of clinical variables and CT radiomic features may facilitate noninvasive assessment of PD-L1 expression. Key points Significant findings of the study Quantitative CT radiomic features can help predict PD-L1 expression, whereas none of the qualitative imaging findings is associated with PD-L1 positivity. What this study adds A prediction model composed of clinical variables and CT radiomic features may facilitate noninvasive assessment of PD-L1 expression.
引用
收藏
页码:993 / 1004
页数:12
相关论文
共 50 条
  • [1] Heterogeneous components of lung adenocarcinomas confer distinct EGFR mutation and PD-L1 expression
    Cai, Yiran
    Wu, Hongbo
    Shi, Xiaoqin
    Dong, Yujie
    Chang, Xiujun
    Zhang, Li
    Zhou, Lijuan
    Su, Dan
    Yang, Ming
    BMC CANCER, 2020, 20 (01)
  • [2] Heterogeneity of PD-L1 Expression in Lung Mixed Adenocarcinomas and Adenosquamous Carcinomas
    Zito Marino, Federica
    Rossi, Giulio
    Montella, Marco
    Botti, Gerardo
    De Cecio, Rossella
    Morabito, Alessandro
    La Manna, Carmine
    Ronchi, Andrea
    Micheli, Mariacarolina
    Salatiello, Giuseppe
    Micheli, Pietro
    Rocco, Danilo
    Accardo, Marina
    Franco, Renato
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2020, 44 (03) : 378 - 386
  • [3] A CT-based radiomics nomogram for prediction of lung adenocarcinomas and granulomatous lesions in patient with solitary sub-centimeter solid nodules
    Chen, Xiangmeng
    Feng, Bao
    Chen, Yehang
    Liu, Kunfeng
    Li, Kunwei
    Duan, Xiaobei
    Hao, Yixiu
    Cui, Enming
    Liu, Zhuangsheng
    Zhang, Chaotong
    Long, Wansheng
    Liu, Xueguo
    CANCER IMAGING, 2020, 20 (01)
  • [4] Predictions of PD-L1 Expression Based on CT Imaging Features in Lung Squamous Cell Carcinoma
    Yeo, Seong Hee
    Yoon, Hyun Jung
    Kim, Injoong
    Kim, Yeo Jin
    Lee, Young
    Cha, Yoon Ki
    Bak, So Hyeon
    JOURNAL OF THE KOREAN SOCIETY OF RADIOLOGY, 2024, 85 (02): : 394 - 408
  • [5] Is there any correlation between spectral CT imaging parameters and PD-L1 expression of lung adenocarcinoma?
    Chen, Mai-Lin
    Shi, An-Hui
    Li, Xiao-ting
    Wei, Yi-Yuan
    Qi, Li-Ping
    Sun, Ying-Shi
    THORACIC CANCER, 2020, 11 (02) : 362 - 368
  • [6] Prediction of PD-L1 expression rate in non-small cell lung cancer based on CT-radiomics
    Xi, Lihong
    Yang, Lingya
    He, Xiaofeng
    Huang, Jingling
    Li, Jun
    Zhong, Daquan
    Huang, Haipeng
    Li, Jiabin
    Zhai, Tiantian
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S5015 - S5019
  • [7] Comparison of PD-L1 Expression Status between Pure-Solid Versus Part-Solid Lung Adenocarcinomas
    Suda, Kenichi
    Shimoji, Masaki
    Shimizu, Shigeki
    Sato, Katsuaki
    Chiba, Masato
    Tomizawa, Kenji
    Takemoto, Toshiki
    Soh, Junichi
    Mitsudomi, Tetsuya
    BIOMOLECULES, 2019, 9 (09)
  • [8] Clinical and molecular correlates of PD-L1 expression in patients with lung adenocarcinomas
    Schoenfeld, A. J.
    Rizvi, H.
    Bandlamudi, C.
    Sauter, J. L.
    Travis, W. D.
    Rekhtman, N.
    Plodkowski, A. J.
    Perez-Johnston, R.
    Sawan, P.
    Beras, A.
    Egger, J. V.
    Ladanyi, M.
    Arbour, K. C.
    Rudin, C. M.
    Riely, G. J.
    Taylor, B. S.
    Donoghue, M. T. A.
    Hellmann, M. D.
    ANNALS OF ONCOLOGY, 2020, 31 (05) : 599 - 608
  • [9] Replication study of PD-L1 status prediction in NSCLC using PET/ CT radiomics
    Stueber, Anna Theresa
    Heimer, Maurice M.
    Ta, Johanna
    Fabritius, Matthias P.
    Hoppe, Boj F.
    Sheikh, Gabriel
    Brendel, Matthias
    Unterrainer, Lena
    Jurmeister, Philip
    Tufman, Amanda
    Ricke, Jens
    Cyran, Clemens C.
    Ingrisch, Michael
    EUROPEAN JOURNAL OF RADIOLOGY, 2025, 183
  • [10] CT-based radiomics analysis for prediction of pathological subtypes of lung adenocarcinoma
    Shao, Yinglong
    Wu, Xiaoming
    Wang, Bo
    Lei, Pengyu
    Chen, Yongchao
    Xu, Xiaomei
    Lai, Xiaobo
    Xu, Jian
    Wang, Jianqing
    JOURNAL OF RADIATION RESEARCH AND APPLIED SCIENCES, 2024, 17 (04)